U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT05774626) titled 'Injectable Contraception Cohort Study in Punjab, Pakistan' on Nov. 28, 2022.
Brief Summary: The aim of this study is to assess the value proposition of expanding contraceptive options available to women in Punjab, Pakistan to include subcutaneous depot medroxyprogesterone acetate (DMPA-SC).
Specific objectives are:
* To compare 12-month continuation rates for DMPA-SC and intramuscular DMPA (DMPA-IM) among married women 18- 49 years of age in two districts of Punjab, Pakistan
* To understand how characteristics and experiences of DMPA-SC and DMPA-IM users differ.
* To assess how well women opting for self-injection of DMPA-SC ad...